Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects

• Váldodahkkit: Hong-Yu Luo (Dahkki), Shuo-Guo Xu (Dahkki), Li-Chen Gao (Dahkki), Hui-Zhi Long (Dahkki), Zi-Wei Zhou (Dahkki), Feng-Jiao Li (Dahkki), Shang-Ming Dai (Dahkki), Jin-Da Hu (Dahkki), Yu Su (Dahkki), Yan Cheng (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Adis, Springer Healthcare, 2024-02-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background Potassium bismuth citrate is a gastric mucosal protector and a key drug for treating peptic ulcers. Objective To evaluate the pharmacokinetic characteristics and safety of 120-mg bismuth potassium citrate formulations administered orally under fasting conditions in healthy Chines...